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Cell fusionThe genome of the inﬂuenza A virus consists of eight different segments. These eight segments are thought
to be sorted selectively in infected cells. However, the cellular compartment where segments are sorted is
not known. We examined using temperature sensitive (ts) mutant viruses and cell fusion where segments
are sorted in infected cells. Different cells were infected with different ts mutant viruses, and these cells were
fused. In fused cells, genome segments are mixed only in the cytoplasm, because M1 prevents their re-import
into the nucleus. We made a marker ts53 virus, which has silent mutations in given segments and
determined the reassortment frequency on all segments using ts1 and marker ts53. In both co-infected and
fused cells, all of marker ts53 segments and ts1 segments were incorporated into progeny virions in a
random fashion. These results suggest that inﬂuenza virus genome segments are sorted after nuclear export.a).
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The inﬂuenza A virus genome is composed of eight single-stranded
negative-sense RNA segments (vRNA). Each genome segment is
complexed with the viral RNA polymerase consisting of three
subunits, PB2, PB1, and PA, and nucleoprotein (NP), thus forming
viral ribonucleoprotein complexes (vRNP). To be infectious, an
inﬂuenza A virus particle must contain at least one copy of each
segment. Two models have been proposed for packaging of the
segmented genome into a virion: the selective-incorporation model
and the random-incorporation model. The random-incorporation
model assumes that vRNPs are randomly incorporated into a virion.
The selective-incorporation model assumes that each segment is
sorted and eight different segments are incorporated into a virion. If
the eight vRNPs are randomly incorporated into a virion, the
probability of the incorporation of eight different segments into a
virion is 0.0024 (8!/88). This calculation value conﬂicts the experi-
mental result that at least 10% of inﬂuenza virus particles are
infectious (Donald and Isaacs, 1954). If more than eight RNPs are
incorporated, the probability that all segments are incorporated into a
virion becomes high. In fact, an inﬂuenza virus virion could
incorporate nine RNPs (Enami et al., 1991). However, almost all
viruses contain eight RNPs as shown by transmission electron
microscopy of serially sectioned virions (Noda et al., 2006), indicating
the selective segment sorting mechanism. Each vRNA segmentcontains a unique “packaging signal” that consists of not only non-
coding region but also coding region of each segment and is necessary
for efﬁcient genome packaging (Fujii et al., 2003; Fujii et al., 2005;
Liang et al., 2005; Muramoto et al., 2006; Ozawa et al., 2007; 2009;
Watanabe et al., 2003). Gao and Palese demonstrated that one virus
can incorporate segment 8 and segment 4 containing segment
8 packaging identity, but the level of the chimeric segment 4 in the
recombinant virus was signiﬁcantly lower than those of the other
segments (Gao and Palese, 2009). Single nucleotide changes in the
packaging signal reduced the segment packaging efﬁciency into a
virion, and further the reduction of the packaging level of the mutant
segment resulted in reduction of that of other segments (Gog et al.,
2007; Hutchinson et al., 2008; 2009; Marsh et al., 2007; 2008;
Muramoto et al., 2006). In addition, a mixed infection of cells by two
different viruses gave rise to progeny viruses that did not ﬁt a random
distribution of all eight segments (Lubeck et al., 1979). From these
reports, it is assumed that genome segments are partly sorted by
RNA–RNA interaction but there is no experimental evidence that
genome segments are directly associated.
Although the evidence that supports the selective-incorporation
model has been accumulating, it is still not known how and where
each segment is sorted in infected cells. The replication and
transcription of the viral genome occur in the nucleus. The replication
of vRNA is a primer-independent and two-step reaction process.
cRNA, the full-sized copy complementary to vRNA, is synthesized
from vRNA, and then the progeny vRNA is synthesized from cRNA as
template. Newly synthesized vRNAs in the nucleus are exported from
the nucleus to the cytoplasm via a CRM1-dependent pathway (Elton
et al., 2001; Watanabe et al., 2001). It is suggested that viral matrix
protein 1 (M1) and nonstructural protein 2 (NS2; also referred to as
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export (Martin and Helenius, 1991a; O'Neill et al., 1998). M1 blocks
the re-import of vRNP to the nucleus (Martin and Helenius, 1991a;
Whittaker et al., 1996). After nuclear export, vRNP is transported to
plasma membrane through unknown pathway and assembled with
viral proteins beneath lipid raft to form progeny virions (Nayak et al.,
2009). In the course of the virion assembly process, one of the
important questions is where segments are sorted. To determine the
intracellular place where segments are sorted would be important to
reveal the segment sorting mechanism. It is possible that vRNA, cRNA,
and viral mRNA would be discriminated from each other, and vRNPs
may be, in part, sorted in the nucleus because the amount of
synthesized vRNA is equal among segments in spite of large difference
in the synthesized level of viral mRNA among segments, and newly
synthesized vRNA is exported to the cytoplasm but cRNA is not
(Shapiro et al., 1987; Tchatalbachev et al., 2001). In addition, it is also
possible that the packaging signal sequence can be recognized from
each other and thus is involved in segment sorting.
In this manuscript, to reveal where inﬂuenza virus RNA segments
are sorted in the infected cells, we have established a new assay using
two different temperature sensitive (ts) mutant strains of inﬂuenza
virus and a cell fusion method. Two different cells are infected with
the two different strains, respectively, and then these cells are fused
after infection. In fused cells, progeny vRNPs derived from two
different viruses are mixed only in the cytoplasm because nuclear re-
import of progeny vRNPs once in the cytoplasm is prevented by M1
(Whittaker et al., 1996). If segments are sorted in the nucleus, the
reassortment frequency in fused cells would be predicted to be low
compared with that in co-infected cells where vRNPs replicated from
different viruses are mixed in the nucleus. Using this assay, we
revealed that all segments are sorted after nuclear export.
Results
An assay to examine whether segmented genome RNAs are assembled in
the nucleus or the cytoplasm
To examinewhere segments are sorted, we tried to establish a new
assay using ts mutant viruses and a cell fusion method (Fig. 1A). The
two different ts mutant viruses derived fromWSN strain, ts1 and ts53,
those of which contains mutations in viral proteins involved in viral
genome replication and transcription, were used in this assay. ts1
contains a mutation in the segment 1 with an amino acid change of
Asp to Asn positioned at residue 417 of PB2 and has a defect in the
viral transcription process (Palese et al., 1977; Sugiura et al., 1972;
Yamanaka et al., 1990). ts53 contains a mutation in the segment 3
with an amino acid change of Leu to Pro positioned at the residue 226
of PA and has a defect in the viral genome replication process but not
transcription process (Kawaguchi et al., 2005; Krug et al., 1975;
Ritchey and Palese, 1977; Sugiura et al., 1975). A Vero cell line
expressing signaling lymphocyte activation molecule (SLAM), desig-
nated Vero-SLAM and HeLa cells expressing measles virus H and F
proteins were infected with ts1 and ts53, respectively. SLAM is a
receptor of measles virus (Tatsuo et al., 2000). Measles virus H protein
binds to SLAM, and F protein induces fusion of membranes (Tatsuo et
al., 2000). Thus, the Vero-SLAM cells and HeLa cells expressing H and F
were fused by mixing. The advantage of this fusion method compared
with the conventional PEG method is the high efﬁciency of cell fusion
and avoiding homokaryon formation. At 1 h after infection, the cells
were washed with MEM adjusted to pH 4.5 to inactivate viruses that
could be associated with cell surface. This treatment did not affect cell
fusion efﬁciency (data not shown). The fused cells could be observed
at 3 h after mixing. It is reported that almost all of incoming vRNP are
transported into the nucleus at 1 h after infection (Martin and
Helenius, 1991b). Thus, it is quite likely that incoming vRNP was
transported into the nucleus before cell fusion and the incomingvRNPs derived from ts1 and ts53 were not mixed in the cytoplasm of
cells. At non-permissive temperature, the viral genome replication
takes place only in nuclei of fused cells because of complementation of
viral proteins in trans. In fused cells, the viral genome is replicated in
each nucleus, that is, ts1 genome segments are replicated in nuclei of
Vero-SLAM cells with viral proteins including non-mutated PB2
translated from ts53 PB2mRNAwhich is synthesized in nuclei of HeLa
cells, and vice versa. The progeny ampliﬁed genome was exported to
the cytoplasm. The progeny genome was not re-imported into the
nucleus by binding M1 to the progeny genome (Whittaker et al.,
1996). To conﬁrm blocking of nuclear re-import of the progeny
genome, we examined the localization/re-localization in fused cells of
NP, which is associated with vRNA. Vero-SLAM cells were infected
with ts1 and/or ts53 and mixed with HeLa cells expressing measles
virus H and F proteins and GFP-B23.1, the latter of which is localized at
nucleoli and thus utilized for a nuclear marker protein of transfected
HeLa cells. The cells were mixed in the presence of cycloheximide to
block the synthesis of viral proteins including NP and thereby prevent
import of any newly synthesized NP to uninfected HeLa cells. NP was
observed in the cytoplasm, but did not accumulate in the nucleus
derived from uninfected HeLa cells (Fig. 1B). When cells were mixed
in the absence of cycloheximide, NP was also observed in the
cytoplasm (data not shown). This result indicates that progeny viral
genome segments of ts1 and ts53 are not re-imported into the nucleus
once after nuclear export. Thus, genome segments derived from ts1
and ts53 was not mixed in the nucleus and was only mixed in the
cytoplasm.
Collection of reassortant virus from fused cells
Using this assay, we determined the reassortment frequency in
fused cells and co-infected cells. If segments are sorted in the nucleus,
the reassortment frequency in fused cells would be predicted to be
much lower than that in co-infected cells where viral genome
segments derived from both viruses are mixed in the nucleus. The
reassortment frequency was determined by plaque assay at both
permissive and non-permissive temperatures. Vero-SLAM cells were
infectedwith ts1 at themultiplicity of infection (MOI) of 10. HeLa cells
expressing H and F were infected with ts53 at an MOI of 1, 3, and 10,
respectively. After incubation at 39.5 °C for 1 h, infected Vero-SLAM
cells and HeLa cells were mixed to be subjected to cell fusion. To
inactivate viruses that were associatedwith cell surface, the cells were
washed with MEM (pH 4.5). At 12 h post infection, the culture
medium was changed to MEM containing 50 μg/ml cycloheximide
because of prevention of viral replication in non-fused cells re-
infected with progeny viruses. The culture medium was collected at
17 h post infection, and the reassortment frequency was determined
by plaque assay at permissive (34 °C) and non-permissive tempera-
ture (39.5 °C). The reassortment frequencywas calculated by a ratio of
the plaque number at non-permissive temperature to that at
permissive temperature. The reassortant wild type WSN virus that
is capable of forming plaque at non-permissive temperature was
generated from fused cells, and the reassortment frequency in the
fused cells was 7.70%, 6.80%, 4.30% at 10:10, 10:3, and 10:1 ratios (ts1/
ts53) of MOI, respectively (Table 1). The progeny virus was not
detected when cells were not subjected to cell fusion, indicating that
the recovery of the reassortant wild typeWSN viruswas not due to co-
infection of remaining viruses (Table 1). These results suggest that
segment 1 and segment 3 are, at least partially, sorted after nuclear
export. As a control experiment, Vero-SLAM cells were co-infected
with ts1 at an MOI of 10 and ts53 at an MOI of 1, 3, and 10,
respectively. The reassortment frequency in co-infected cells was
13.6%, 10.3%, 5.27% at 10:10, 10:3, and 10:1 ratios of MOI, respectively
(Table 1). The reassortant virus was recovered from fused cells, and
the reassortment frequency in co-infected cells was a little higher
than that in fused cells.
Fig. 1. Schematic representation of an assay system used for examination of segment sorting place. (A) Fused cell assay using ts1 and ts53. Vero-SLAM cells were infected with ts1,
while HeLa cells expressing measles virus H and F proteins were infected with ts53. The cells were fused by mixing after infection. In fused cells, progeny genome RNAs were not re-
imported into the nucleus byM1-mediatedmechanism (Martin and Helenius, 1991a;Whittaker et al., 1996), and thus segments weremixed only in the cytoplasm. The reassortment
frequency was determined by plaque assay at permissive temperature and non-permissive temperature. (B) Localization of NP in fused cells infected with ts1 and/or ts53. The Vero-
SLAM cells were infected with ts1 and/or ts53 at an MOI of 3, and the infected cells were fused to HeLa cells expressing GFP-B23.1 and measles virus H and F at 12 h after infection.
After incubation for 4 h in themedium containing 50 μg/ml cycloheximide, the cells were ﬁxed, and NPwas visualized by indirect immunoﬂuorescence. Arrows indicate nuclei (GFP-
B23.1-positive nuclei) derived from uninfected HeLa cells, and arrowheads indicate nuclei derived from infected Vero-SLAM cells.
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ts53 in fused cells
The reassortant virus was recovered from fused cells, although the
reassortment frequency in co-infected cells was higher than that in
fused cells (Table 1). In theory, the reassortment frequency variesdepending on the ratio of vRNA ampliﬁed from ts1 and ts53, and the
partial segment assembly also reduces the reassortment frequency.
Thus, to compare the reassortment frequency between co-infected
cells and fused cells, the reassortment frequency needs to be corrected
as a function of the amount of vRNA derived from ts1 relative to that
from ts53 in co-infected cells and fused cells, respectively. The outline
Table 1
Recovery of reassortant viruses from fused cells.
Ratio of MOI
(ts53/ts1)
Titer (PFU/ml) Reassortment
frequency
(%)
34 °C 39.5 °C
Co-infection 0.1 4.32×104 2.28×103 5.27
0.3 3.80×104 3.95×103 10.3
1 4.28×104 5.85×103 13.6
Fusion(+) 0.1 1.20×103 5.16×101 4.30
0.3 6.36×103 4.33×102 6.80
1 2.27×104 1.75×103 7.70
Fusion(−) 1 n.d.a n.d.a
a n.d.: not detected.
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derived from ts1 relative to that from ts53 is described in Fig. 2A.
Using a mutated primer for RT-PCR, we could introduce a BamHI site
in RT-PCR products derived from segment 1 of ts53. The segment 1
DNA fragment derived from ts53 could be digested, but that from ts1
could not be digested with BamHI. The digested DNA fragments were
separated through PAGE, and the band intensity was determined.
Vero-SLAM cells were infected with ts1 at anMOI of 10, and HeLa cells
expressing H and F were infected with ts53 at an MOI of 1, 3, and 10,
respectively. After incubation at 39.5 °C for 1 h, the infected cells were
mixed to fuse cells. As a control experiment, Vero-SLAM cells were co-
infected with both ts1 at an MOI of 10 and ts53 at an MOI of 1, 3, and
10, respectively. Total RNA was extracted from fused cells and co-
infected cells at 17 h post infection. To increase the quantitative
reliability, low-cycle RT-PCR was performed in the presence of [32P]-
dCTP. In co-infected cells, the amounts of ts53 segment 1 vRNAFig. 2. Determination of the replication efﬁciency of segment 1 in fused cells. (A) A metho
primers were constructed to make a BamHI site only in PCR product from the ts53 sequence
by BamHI, but PCR product DNAs derived from segment 1 vRNA of ts1 are not. DNA fragme
vRNA derived from ts53 relative to that from ts1 in co-infected cells and fused cells. Total R
[32P]-dCTP. The ampliﬁed products were digested with BamHI and separated through PAGE. T
using an image analyzer, and the ratio of the band intensity for DNA from ts53 relative to trelative to that of ts1 segment 1 vRNA were 0.27, 0.42, and 0.65 at
10:10, 10:3, and 10:1 ratio of MOI, respectively, and in fused cells,
those were 0.19, 0.23, and 0.30, respectively (Fig. 2B). It is apparent
that the amount of segment 1 vRNA derived from ts53 in fused cells
was lower than that in co-infected cells. To compare the reassortment
frequency in fused cells with that in co-infected cells, the reassort-
ment frequency as a function of the relative amount of segment 1
vRNAwas plotted on the graph, and the reassortment frequency at 1:1
ratio in the amount of ts1 segment 1 vRNA and that of ts53 segment 1
vRNA was deduced by calculation using ﬁtting plots according to
nonlinear least-squares method (Fig. 3). The ﬁtted curve for fused
cells was y=−15.02 x2+30.04×(R2=0.80), and the reassortment
frequency was 15.0% when the ratio of the amount of ts1 segment 1
relative to that of ts53 segment 1 is set to be 1. The ﬁtted curve for co-
infected cells was y=−14.86 x2+29.72×(R2=0.91), and the
reassortment frequency is 14.9%. Thus, the reassortment frequency
in fused cells was almost the same as that in co-infected cells. These
results support the notion that segment 1 and segment 3 are sorted
after nuclear export. However, there is a possibility that remaining
viruses co-infect to the uninfected cells and incoming vRNP segments
are reassorted right after uncoating of virions and release of vRNPs
into the cytoplasm before their nuclear transport. On this line, the
virus titer at 6 h and 8 h after infection at fused cells was determined
by plaque assay, and no plaque was observed (data not shown).
Furthermore, the experimental observation below would strengthen
the notion: HeLa cells infected with ts53 were fused with uninfected
Vero-SLAM cells, and the fused cells were super-infected with ts1
(200 PFU) at 10 h after the ﬁrst infection. Themediumwas changed at
12 h after the second infection. At 17 h after the second infection,
however, we could not detect any virus in plaque assay (data notd for determination of the amount of segment 1 vRNA derived from ts1 and ts53. PCR
. After RT-PCR, PCR product DNAs derived from segment 1 vRNA of ts53 can be digested
nts were separated through PAGE after BamHI digestion. (B) The amount of segment 1
NA in co-infected cells and fused cells were extracted, and RT-PCR was performed with
he amount of DNA bands derived from segment 1 vRNAwas quantitatively determined
hat from ts1 was calculated and indicated below the panel.
Fig. 3. The reassortment frequency in co-infected cells and fused cells. The reassortment
frequency in fused cells (square) and co-infected cells (diamond) were plotted as a
function of the relative amount of segment 1. These plots were ﬁtted using a nonlinear
least-squares method. The solid line is the ﬁtted curve for co-infected cells, and the
dotted line is that for fused cells.
252 N. Takizawa et al. / Virology 401 (2010) 248–256shown). These results suggest that reassortant viruswas not produced
either by co-infection of possible remaining viruses or reassortment
between incoming vRNA segments.
Determination of the reassortment frequency for every set of two
segments
As above, the reassortment frequency between segment 1 and
segment 3 was determined using ts1 and ts53. However, it is possible
that segments in other combinations could be partially sorted in the
nucleus. Thus, we determined the reassortment frequency in other
segment combinations in fused cells and co-infected cells and tried to
answer whether segment sorting occurs after nuclear export. To this
end, wemademarker ts53 viruses, each of which has a silentmutation
in a given segment except for segment 3. Vero-SLAM cells infected
with ts1 and HeLa cells expressing H and F infected with marker ts53
was mixed, and the supernatant was collected in the same way. To
determine the reassortment frequency in co-infected cells and fused
cells, approximately 50 independent progeny viruses were isolated by
plaque isolation, and RT-PCR was performed with the primers which
provide restriction enzyme sites at mutation sites (Fig. 4A). The origin
of each segment in an isolated virus was determined by the sensitivity
to restriction enzymes. By doing so, we could determine which
segments are derived from ts1 or marker ts53 in a virus. HeLa cells
expressing H and F infected with the marker ts53 was mixed and
fused with Vero-SLAM infected with ts1 at non-permissive temper-
ature. In addition, Vero-SLAM cells were co-infected with both ts1 and
marker ts53 as a control experiment. The plaque assay was carried out
at permissive temperature, and 53 and 48 plaque forming progeny
viruses were isolated from co-infected cells and fused cells, respec-
tively. Total RNA for RT-PCR was extracted from cells infected with
each isolated virus. After RT-PCR, ampliﬁed DNA was subjected to the
restriction enzyme sensitivity assay. One of the representative results
about segment 3 of isolated viruses from fused cells is shown in
Fig. 4B. The summary of segment composition of each isolated virus
was described in Table S1 (co-infected cells) and Table S2 (fused
cells), and the isolated viruses were sorted by the number of segments
derived from ts1 (Table 2). Four isolated viruses from fused cells
contained all segments derived from marker ts53, but the virus that
contained one segment derived from ts1 was not collected (Table 2).
Thus, the four viruses that contained all segments derived from
marker ts53 were assumed to be due to contamination and thus
eliminated for analysis. The number of each segment derived from ts1or marker ts53 in isolated viruses was summarized in Table 3. Based
on these results, the expected value for random distribution of a set of
two segments derived from ts1 (expected segment-set speciﬁc value;
ess value) was calculated. For example, 19 and 21 of isolated viruses
from co-infected cells contained segment 1 and segment 2 derived
from ts1, respectively, while the total number of isolated viruses was
53 (Table 3). The ess value for both segment 1 and segment 2 that
were derived from ts1 in co-infected cells was 7.53 (19/53×21/
53×53). This valuemeans that 7.53 isolated viruses out of 100 viruses
would be expected to contain both segment 1 and segment 2 from ts1.
If the observed number of the isolated virus that contains both
segment 1 and segment 2 from ts1 is higher than the ess values, it
seems quite likely that these two segments tend to be co-packaged
into a virion, and thus there could be some interaction between these
two segments. The observed number of isolated viruses that contain a
given set of two segments (designated niv) and ess values was
described in Table 4 (co-infected cells) and Table 5 (fused cells). From
the results of co-infected cells, we could not detect any signiﬁcant
difference between niv and ess values in all sets of two segments
(Table 4). To analyze in more detail, we calculated niv and ess values
of each set of two segments and determined the probability of random
distribution of a set of two segments by χ2 analysis (Table S3). The
probabilities of all sets of two segments were much more than 0.05,
strongly suggesting that genome segment of ts1 and that of marker
ts53 are evenly distributed into progeny viruses by co-infection. These
results indicate that the same segments that are derived from the
same genetic background strains are not distinguished in co-infected
cells. The same result was also obtained in the case of fused cells
(Table 5 and Table S4). These results suggest that the all segments are
sorted after nuclear export.
Discussion
There is increasing evidence to support selective-incorporation
model, but the molecular mechanism and the cellular compartment
for segment sorting are totally unknown. We established a new assay
system using ts mutant strains and a cell fusion method to reveal
where inﬂuenza genome segments are sorted.With thesewe revealed
that inﬂuenza virus RNA segments are sorted after nuclear export. It is
reported that almost all of incoming vRNP are transported into the
nucleus at 1 h after infection (Martin and Helenius, 1991b) and about
60% of fusion-active viruses have fused at 20 min after adsorption
(Lakadamyali et al., 2003). In our system, the infected cells were
mixed at 1 h after infection. We reported that it takes about 1 h for a
half of measles virus to infect the cells expressing SLAM through viral
glycoproteins (Okada et al., 2009). Thus, it is quite likely that all of
incoming vRNPs were imported into the nucleus before cell fusion.
Furthermore, progeny virus was not detected when fused cells which
had been infected with ts53 were super-infected with ts1 (data not
shown), suggesting that almost all incoming vRNPs were transported
into the nucleus under the condition employed here and reassortment
did not occur between incoming vRNPs in the cytoplasm. The progeny
vRNPs were ampliﬁed in each nucleus and exported to the cytoplasm.
Each progeny vRNP was only mixed in the cytoplasm because the
nuclear exported progeny vRNPs were not re-imported into the
nucleus (Fig. 1B). We conclude that inﬂuenza virus genome segments
are sorted after nuclear export because the reassortment frequency
between co-infected cells and fused cells was not different (Fig. 3,
Tables 4 and 5).
For generation of an infectious inﬂuenza virus particle, it is
reasonably assumed that there exists the mechanism for discrimina-
tion of viral RNAs from cellular RNAs. vRNA, cRNA, and cellular RNAs
should be discriminated from each other because neither cRNA nor
cellular RNAs are associated with virions. The vRNA could be
distinguished from cellular RNAs by the vRNP structure. Tchatalba-
chev et al. reported that vRNA is distinguished from cRNA by the 5′-
Fig. 4.Determination of the reassortment frequency in every combination of two segments. (A) The outline of the fused cell assay using ts1 andmarker ts53. Vero-SLAM cells infected
with ts1 and HeLa cells expressing measles virus H and F proteins infected with marker ts53 were fused by mixing after infection. The culture supernatant was collected, and
reassortant viruses were isolated by single plaque isolation. By identifying the origin of each segment in an isolated virus with RT-PCR and the restriction enzyme sensitivity assay,
the reassortment frequency between a set of two segments was determined. (B) Identiﬁcation of the origin of segment 3 vRNA in a plaque-isolated virus from fused cells. Total RNA
was extracted from cells infected with each isolated virus and RT-PCR was performed. The ampliﬁed products were subjected to digestion with AatI in the case of segment 3 and
separated through PAGE. The AatI-sensitive product was derived from ts1, and the AatI-insensitive product was derived from marker ts53.
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associated with this conformation appears to be recognized for
nuclear export (Tchatalbachev et al., 2001). In addition, during
assembly of infectious virions, eight kinds of segments must be
incorporated into a virion, so that each segment must be discrimi-
nated and sorted in infected cells. It would be possible that RNA–RNA
interaction is involved in segment sorting because the vRNA
sequences that are necessary for efﬁcient inﬂuenza virus genome
packaging have been identiﬁed (Fujii et al., 2003; Fujii et al., 2005; GogTable 2
The number of viruses containing the segments derived from ts1.
Number of segments derived from ts1 0 1 2 3 4 5 6 7 8
Co-infection 1 2 2 17 15 14 2 0 0
Fusion 4 0 2 3 3 9 10 11 6et al., 2007; Hutchinson et al., 2008; 2009; Liang et al., 2005; 2008;
Marsh et al., 2007; 2008; Muramoto et al., 2006; Ozawa et al., 2007;
2009; Watanabe et al., 2003). The fact that vRNP can be digested by
RNaseH in the presence of an anti-sense oligodeoxyribonucleotide
speciﬁc for a vRNA sequence (Enami and Enami, 2000) supports that
vRNP has a potential to make intramolecular or intermolecular RNA–
RNA interactions. However, such the segment–segment interaction
among inﬂuenza virus genome segments is not clearly shown. It is
well known that retrovirus contains two identical copies of the RNA
genome within a virion, and these RNA genomes are non-covalently
joined together (Paillart et al., 2004). In the case of HIV-1 and Rous
sarcoma virus, it is thought that the trafﬁcking Gag into and out of the
nucleus is crucial for viral assembly and dimerization of the RNA
genome (Dupont et al., 1999; Garbitt et al., 2001; Parent et al., 2000;
Scheifele et al., 2002), but it is not clear whether dimerization of the
retroviral RNA genome occurs in the nucleus. Here we have
Table 3
The number of each segment derived from ts1 or marker ts53 in isolated viruses.
Co-infection Fusion
ts1 Marker ts53 ts1 Marker ts53
Segment 1 19 34 25a 17a
Segment 2 21 32 25 19
Segment 3 24b 27b 24 20
Segment 4 21c 30c 36 8
Segment 5 32 21 35 9
Segment 6 26d 25d 34e 9e
Segment 7 29f 23f 37 7
Segment 8 27g 24g 38 6
a DNA could not be ampliﬁed from two isolated viruses.
b DNA could not be ampliﬁed from two isolated viruses.
c Two bands were detected from two isolated viruses.
d Two bands were detected from two isolated viruses.
e DNA could not be ampliﬁed from one isolated virus.
f Two bands were detected from one isolated virus.
g DNA could not be ampliﬁed from two isolated viruses.
Table 5
The number of isolated viruses containing a set of two segments in fused cells.
Seg 1 Seg 2 Seg 3 Seg 4 Seg 5 Seg 6 Seg 7 Seg 8
Seg 1
Seg 2 14/14.2a
Seg 3 15/13.6 14/13.6
Seg 4 22/20.5 20/20.5 20/19.6
Seg 5 21/19.9 19/19.9 22/19.1 30/28.6
Seg 6 21/19.3 23/19.3 21/18.5 29/27.8 28/27.0
Seg 7 22/21.0 21/21.0 19/20.2 32/30.3 32/29.4 30/26.3
Seg 8 22/21.6 23/21.6 21/20.7 32/31.1 32/30.2 31/28.6 32/32.0
a Each set of numbers indicates niv value/ess value. niv value, the number of isolated
viruses containing a set of two segments derived from ts1; ess value, the expected value
of a set of two segments derived from ts1 in fused cells.
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sorted after nuclear export. This further suggests that segments could
not be sorted and assembled solely by simple RNA–RNA interaction in
the nucleus.
After nuclear export, vRNPs move to plasma membrane. The viral
membrane proteins are transported to plasmamembrane via ER-golgi
pathway. It is assumed that the vRNP are transported to plasma
membrane by binding the cytoplasmic tail of HA through M1,
although the precise mechanism of the transport of vRNPs to plasma
membrane is still an open question (Nayak et al., 2009). Cytoskeleton
and microtubule are cellular structures involved in various cellular
processes and could be possible structures involved in vRNP transport.
However, the production of inﬂuenza virions was not reduced by the
disruption of these cellular structures by speciﬁc inhibitors (Roberts
and Compans, 1998). Based on these, it is assumed that segments are
sorted and assembled under the plasma membrane rather than in the
cytoplasm. The lipid raft microdomains are enriched in sphingomyelin
and cholesterol, and function as the site for budding of several
envelope viruses including inﬂuenza virus (Takeda et al., 2003). The
lipid raft microdomain is a candidate site of segment sorting as a
scaffold. However, there is no evidence supporting this idea at the
molecular level.
Under the conditions employed here, the replication efﬁciency of
inﬂuenza virus in HeLa cells was different from that in Vero-SLAM
cells (Fig. 2). Thus, the reassortment frequency was plotted as a
function of the relative amount of each segment, and the plots were
ﬁtted to determine the reassortment frequency when the amount of
the segment in HeLa cells relative to that in Vero-SLAM cells was set to
be 1 (Fig. 3). The number of segments derived from ts1 packed in a
virion in co-infected cells (about 4 segments derived from ts1 per
virion on the average) was different from that in fused cells (about 6Table 4
The number of isolated viruses containing a set of two segments in co-infected cells.
Seg 1 Seg 2 Seg 3 Seg 4 Seg 5 Seg 6 Seg 7 Seg 8
Seg 1
Seg 2 7/7.53a
Seg 3 10/8.60 8/9.51
Seg 4 11/7.53 9/8.32 10/9.51
Seg 5 13/11.5 13/12.7 11/14.5 14/12.7
Seg 6 9/9.32 5/10.3 12/11.8 10/10.3 16/15.7
Seg 7 10/10.4 12/11.5 11/13.1 8/11.5 18/17.5 12/14.2
Seg 8 8/9.68 11/10.7 12/12.2 11/10.7 15/16.3 10/13.3 17/14.8
a Each set of numbers indicates niv value/ess value. niv value, the number of isolated
viruses containing a set of two segments derived from ts1; ess value, the expected value
of a set of two segments derived from ts1 in co-infected cells.segments derived from ts1 per virion on the average) (Table 2). This
difference could be explained by the difference in the replication
efﬁciency in HeLa cells and Vero-SLAM cells. The number of segments
derived from ts1 in fused cell was higher than that from ts53 (Fig. 2B
and Table 3). Moreover, the number of small segments (from segment
4 to segment 8) derived from marker ts53 was smaller than that of
large segments (from segment 1 to segment 3) in both co-infected
cells and fused cells (Table 3), although any speciﬁc packaging
combination between segments was not detected (Tables S3 and S4).
These results indicate that not only the total number of replicated
vRNA but also the replication rate among segments was different
between ts1-infected HeLa cells and ts53-infected Vero-SLAM cells.
The theoretical reassortment frequency is 25% when the ratio of
RNA amounts derived and ampliﬁed from both viruses is 1:1, but the
reassortment frequency was about 15% in fused cells and co-infected
cells (Fig. 3). This difference could be due to our method for
determination of reassortment frequency, in part. The reassortment
frequency was determined by plaque assay at non-permissive
temperature (39.5 °C). At non-permissive temperature, the virus
titer is slightly decreased even for the wild type WSN virus. Indeed,
the theoretical reassortment frequency was observed, when the
reassortment frequency was determined by direct sequencing (Tables
S3 and S4).
Lubeck et al. reported that co-infection of two different viruses
gave rise to progeny viruses in which the segments were not
distributed in agreement with theoretical expectation (Lubeck et al.,
1979). In our experiment using the same background strains for
infection, these segment sets were distributed in progeny virus by
theoretical expectation (Tables S3 and S4). This discrepancy could be
due to the previous study that used different subtype strains for co-
infection. In their experiments, the reassortment frequency between
the segments encoding viral polymerases was much lower than
expected (Lubeck et al., 1979). This result could be explained by
unexpected virus selection, because the point mutations in viral
polymerase subunits and the combination of viral polymerase
subunits derived from different strains highly affect viral polymerase
activity (Naffkh et al., 2008).
In conclusion, we established a new assay system using ts mutant
viruses and cell fusion and revealed that the genome segments of
inﬂuenza virus are sorted after nuclear export. The sorting and
assembly of segments are crucial for not only production of infectious
virions but also generation of reassortant viruses that are candidates
for pandemic inﬂuenza viruses. The RNA sequence of each segment is
thought to be important for segment sorting. However, the mecha-
nism of segment sorting is still unknown, although the packaging
signal in each segment is identiﬁed. Our results suggest that, at least in
the nucleus, segments are not sorted only by simple RNA–RNA
interaction between segments. The determination of the exact cellular
compartment where segments are sorted will contribute to revealing
the segment sorting mechanism. Further studies to clarify exact
255N. Takizawa et al. / Virology 401 (2010) 248–256cellular compartment of segments sorting will be necessary to
understand the molecular mechanism of segment sorting.
Materials and methods
Cells and viruses
HeLa, Vero-SLAM, MDCK, and MDBK cells were grown in minimal
essential medium (MEM) (Nissui) containing 10% fetal bovine serum.
Vero-SLAM cells were kindly provided by Y. Yanagi (Ono et al., 2001).
293T cells were grown in Dulbecco's modiﬁed Eagle's medium
(DMEM) (Nissui) containing 10% fetal bovine serum. Inﬂuenza virus
ts mutants, ts1 (Sugiura et al., 1972; Yamanaka et al., 1990) and ts53
(Kawaguchi et al., 2005; Sugiura et al., 1975), were grown at 34 °C for
48 h in allantoic sacs of 11 day-old embryonated eggs, and the virus
titer was determined by plaque assay using MDCK cells.
Vectors
The expression vectors of measles virus H and F proteins and B23.1,
pCA-IC-F and pCA-IC-H, and pEGFP-Flag-B23.1, were described previ-
ously (Okuwaki et al., 2002; Takeuchi et al., 2002). Viral protein
expression vectors and viral RNA expression vectors for reverse genetic
systemwere kindly provided by Y. Kawaoka (Neumann et al., 1999). To
make pPolI-WSN-PB1-T504C, pPolI-WSN-HA-C470T, pPolI-WSN-NA-
T331C, pPolI-WSN-M-A289G, and pPolI-WSN-NS-A215G, inverted PCR
was carried out using pPolI-WSN-PB1, pPolI-WSN-HA, pPolI-WSN-NA,
pPolI-WSN-M, and pPolI-WSN-NS as templates with speciﬁc primer
sets, Seg2-T504Crev (5′–GGATTCATTGGCCGTGAGGC–3′) and Seg2-
505for (5′–GGAAGGCTCATAGACTTCCTTA–3′), Seg4-C470Trev (5′–ATT-
GAATGTGTGGTTGGGCC–3′) and Seg4-471for (5′–GGAGTAACAGTAT-
CATGCTCC–3′), Seg6-T331Crev (5′–GGGCTCTCTTATGACAAAAACGTCT–
3′) and Seg6-332for (5′–TTTATTTCATGTTCTCACTTGGAATG–3′), Seg7-
A289Gfor (5′–GGATCCAAATAACATGGACAAAGCAG–3′) and Seg7-
A289Grev (5′–CCGTTCCCATTAAGAGCATTTTG–3′), and Seg8-A215Gfor
(5′–GATAGTGGAGCGGATTCTGAAGG–3′) and Seg8-A215rev (5′–
TGCTTTCCAGCACGGGTGG–3′), respectively. The PCR products were
phosphorylated and ligated. TomakepPolI-WSN-PB2-A498G andpPolI-
WSN-HA-A306G, PCR was carried out using pPolI-WSN-PB2 and pPolI-
WSN-HA as templates with speciﬁc primer sets, Ba-PB2-1 and PB2-
A498Grev (5′–CATGATTACATCCTGTGCCTCCTTGG–3′), PB2-A498Gfor
(5′–CCAAGGAGGCACAGGATGTAATCATG–3′) and Ba-PB2-2341R, Bm-
NP-1 and NP-A306Grev (5′–CCAGTTTTCTTAGGATCCTTCCCCG–3′), and
NP-A306Gfor (5′–CGGGGAAGGATCCTAAGAAAACTGG–3′) and Bm-NP-
1565R, respectively. The primer sequences of Ba-PB2-1, Ba-PB2-2341R,
Bm-NP-1, and Bm-NP-1565R were described by Hoffmann et al.
(Hoffmann et al., 2001). The second PCR was carried out using the
PCR products as templates with Ba-PB2-1 and Ba-PB2-2341R, and Bm-
NP-1 and Bm-NP-1565R, respectively. The ampliﬁed products were
digested with BsaI for PB2 segment or BsmBI for NP segment and
inserted into the BsmBI site of pHH21. pPolI-PA-ts53 was described
previously (Kawaguchi et al., 2005).
Cell fusion assay
HeLa cells were transfected with pCA-IC-F and pCA-IC-H by the
CaPO4 method. Vero-SLAM cells and HeLa cells expressing both H and
F were infected with ts1 and ts53, respectively. After adsorption at
39.5 °C (non-permissive temperature) for 1 h, the cells were
incubated at room temperature for 5 min in MEM (pH 4.5) for
inactivation of remaining virions. The infected Vero-SLAM cells were
mixed to the HeLa cells in fresh MEM. The fused cells could be
observed at 3 h after mix. After incubation at 39.5 °C for 11 h, the cell
culture medium was changed to MEM containing 50 μg/ml cyclohex-
imide. At 17 h post infection, the cultured supernatant was collected,
and the virus titer was determined by plaque assay.Indirect immunoﬂuorescence
The cells on coverslips were ﬁxed by 4% paraformaldehyde in PBS.
The cells were permeabilized by 0.1% NP-40 in PBS at room
temperature for 10 min and then immersed in 1% nonfat dry milk in
PBS at room temperature for 1 h. Then, the cells were incubated at
room temperature for 1 h with anti-NP antibody, mAb61A5 (Momose
et al., 2007). This antibody preferentially interacted with NP on RNP
rather than a free form of NP. The cells were washed with 0.1% NP-40
in PBS and incubated at room temperature for 1 h with an Alexa 568-
conjugated anti-mouse IgG (Invitrogen), followed by incubation with
3 μM4′, 6′-diamidino-2-phenylindole (DAPI) at room temperature for
5 min. The coverslips were mounted on glass plates, and the cells
were observed under a ﬂuorescence microscope (Carl Zeiss).Recombinant virus
A marker virus which contains silent point mutations in all
segments was generated by reverse genetics (Neumann et al., 1999).
293T cells were transfected with viral protein expression vectors
(PB1, PB2, PA, and NP) and viral RNA expression vectors. After
incubation for 48 h post transfection, the cell culture supernatant was
used for virus ampliﬁcation in MDBK cells. At 48 h post infection, the
cell culture supernatant was collected, and stored until use. The virus
titer was determined by plaque assay.RT-PCR
The total RNA was extracted with the guanidine thiocyanate
method. To determine the amount of segment 1 vRNA derived from
ts53 relative to that from ts1, total RNA was reverse-transcribed using
reverse transcriptase (Toyobo) and a primer, PB2-1837for (5′–
AGGGATGTGCTTGGGACATTTG–3′). The cDNA was ampliﬁed by low-
cycle PCR with [32P]-dCTP using primers, PB2-1837for and PB2-
2037cut-rev (5′–TCTGGGTCTTCAGTTAAAGGGCCAGGA–3′). The PCR
product was digested with BamHI and separated through PAGE. The
separated products were detected by autoradiography, and the
relative amount of segment 1 vRNA was quantitatively determined
using an image analyzer (Fujiﬁlm). To identify which each segment is
derived from ts1 or marker ts53, total RNA was reverse-transcribed
using reverse transcriptase and Uni12 primer (Hoffmann et al., 2001).
The cDNAwas ampliﬁed by PCR using primer sets, Seg1-496-DraI (5′–
TCCTGGTCATGCAGATCTCAGTTTTAA–3′) and Seg1-720rev (5′–
CACTTCAATGTACACACTGCTTGTTC–3′) for segment 1, Seg2-499-
BamHI (5′–AAATGGCCTCACGGCCAATGGATC–3′) and Seg2-745rev
(5′–TTGCTCTCCGTTTTAGCTTCCCTCT–3′) for segment 2, PA695cut
(5′–TCTCCCGCCAAACTTCTCAGGCC–3′) and PA895rev (5′–TTAATTT-
TAAGGCATCCATCAGCAGG–3′) for segment 3 of ts53, Seg4-467-HpaI
(5′–GTTCATGGCCCAACCACACAGTTAA–3′) and Seg4-761rev (5′–
CATCCTCCCATGTTGATCTTTTACTTTG–3′) for segment 4, NP-for (5′–
GGAATTCCATATGGCGTCTCAAGGCACCAAACG–3′) and Seg5-366-Hin-
dIII (5′–ATATAGGTCCTCCAGTTTTCTTAGAAGC–3′) for segment 5,
Seg6-328-stuI (5′–AAGGAGACGTTTTTGTCATAAGAAGGCC–3′) and
Seg6-750rev (5′–TTCTCGATCTTGAAAATTTTAGGC–3′) for segment 6,
Seg7-340rev (5′–CCTCTTAAGCTTCCTATACAGTTTAACTGC–3′) and
M2-for (5′–ATGAGTCTTCTAACCGAGGTCGAACG–3′) for segment 7,
and NS2-for (5′–GGAATTCCATATGGATCCAAACACTGTGTCAAGCTTT-
CAG–3′) and Seg8-217cut (5′–GATTCTTCCTTCAGAATCCGCTCCGA-
TAT–3′) for segment 8, respectively. The PCR product was digested
with DraI (Segment 1), BamHI (Segment 2), AatI (Segment 3, ts53),
HpaI (Segment 4), HindIII (Segment 5), StuI (Segment 6), BamHI
(Segment 7), or EcoRV (Segment 8) and separated with PAGE. The
products were stained with ethidium bromide and visualized by UV
illumination.
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